全文获取类型
收费全文 | 413篇 |
免费 | 37篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 9篇 |
妇产科学 | 13篇 |
基础医学 | 52篇 |
口腔科学 | 7篇 |
临床医学 | 29篇 |
内科学 | 112篇 |
皮肤病学 | 1篇 |
神经病学 | 21篇 |
特种医学 | 49篇 |
外科学 | 66篇 |
综合类 | 6篇 |
预防医学 | 36篇 |
眼科学 | 2篇 |
药学 | 28篇 |
1篇 | |
肿瘤学 | 17篇 |
出版年
2022年 | 6篇 |
2021年 | 5篇 |
2020年 | 6篇 |
2019年 | 11篇 |
2018年 | 14篇 |
2017年 | 14篇 |
2016年 | 10篇 |
2015年 | 10篇 |
2014年 | 10篇 |
2013年 | 21篇 |
2012年 | 12篇 |
2011年 | 21篇 |
2010年 | 12篇 |
2009年 | 7篇 |
2008年 | 15篇 |
2007年 | 13篇 |
2006年 | 7篇 |
2005年 | 12篇 |
2004年 | 16篇 |
2003年 | 17篇 |
2002年 | 9篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 6篇 |
1998年 | 16篇 |
1997年 | 6篇 |
1996年 | 10篇 |
1995年 | 3篇 |
1994年 | 9篇 |
1993年 | 7篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 12篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 4篇 |
1984年 | 7篇 |
1983年 | 11篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 7篇 |
1975年 | 5篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1971年 | 3篇 |
1970年 | 4篇 |
排序方式: 共有453条查询结果,搜索用时 0 毫秒
451.
452.
Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage
453.
AB Gago-Veiga J-I Huhn N Latysheva A Vieira Campos M Torres-Ferrus A Alpuente Ruiz S Sacco I Frattale R Ornello R Ruscheweyh IB Marques A Gryglas-Dworak C Stark VJ Gallardo P Pozo-Rosich 《The journal of headache and pain》2021,22(1)
BackgroundThere is currently a wide therapeutic arsenal for migraine patients, without a single first-line preventive drug and we choose the different available alternatives taking into account comorbidities, national guidelines, previous treatments and personal experiences.Our objective was to evaluate the differences in the use of migraine treatments between neurologists from different countries.MethodsThis is a multi-centre observational study carried out by neurologists from specialized headache units in seven countries, retrospective with consecutive inclusion of all patients presenting with a migraine diagnosis, over a period of three months.ResultsA total of 734 patients were recruited but only 600 were considered in the analysis in order to homogenize the patient cohorts from countries: 200 Spain (ES), 100 Italy (IT), 85 Russia (RUS), 80 Germany (DE), 60 Portugal (PT), 45 Poland (PL) and 30 Australia (AU). 85.4 % of patients were women with a mean age of 42.6 ± 11.8 years. Considering previous and current preventive treatment, the order of use was: antidepressants (69.3 %), antiepileptic drugs (54.7 %), beta-blockers and antihypertensive drugs (49.7 %), OnabotulinumtoxinA (44.0 %) and others (36.2 %).Statistically significant differences were found between all pharmacological classes: antidepressants were commonly used in all countries, with the exception of Poland (AU: 76.7 %, IT: 71.0 %, DE: 60.0 %, PL: 31.1 %, PT: 71.7 %, RUS: 70.6 %, ES: 78.5 %; p < 0.0001); antiepileptic drugs were more frequently prescribed in Portugal, Australia and Spain (AU: 73.3 %, IT: 40.0 %, DE: 37.5 %, PL: 48.9 %, PT: 85.0 %, RUS: 29.4 % and ES: 69.0 %; p < 0.0001); beta-blockers and antihypertensive drugs were frequently used in all countries except Italy (AU: 60.0 %, IT: 14.0 %, DE: 53.8 %, PL: 48.9 %, PT: 68.3 %, RUS: 49.4 % and ES: 59.0 %; p < 0.0001); BTX-A were predominately used in Spain, Italy and Australia (AU:56.7 %, IT:58.0 %, DE:20.0 %, PL: 42.2 %, PT: 26.7 %, RUS: 24.7 % and ES: 58.5 %; p < 0.0001) and others were most frequently used in Poland (AU: 0.0 %, IT: 19.0 %, DE: 42.5 %, PL: 95.6 %, PT: 31.7 %, RUS: 3.5 % and ES: 49.5 %; p < 0.0001). If only patients without comorbidities are considered (200/600), statistically differences between countries persist in all preventive treatments.ConclusionsThere is heterogeneity in the choice of preventive treatment between different countries. Prospective comparative studies of the different oral and subcutaneous alternatives would help to create a global therapeutic algorithm that would guarantee the best option for our patients. 相似文献